Browse articles from EyeWorld.org related to trifocals. EyeWorld is the award-winning member publication of ASCRS. The magazine provides news and updates from the Society as well as clinical features in the areas of cataract, refractive, cornea, glaucoma, and practice management. It publishes quarterly with editorial direction from its medical editorial board and staff.
The large number of patients worldwide with presbyopia creates a unique opportunity for eyecare providers to improve patients’ quality of life, according to George Waring IV, MD, FACS. He and Shamik Bafna, MD, discussed some of the surgical and pharmacological options.
➤ Investigating adjuvant therapy to DSO for Fuchs ➤ FDA approves loteprednol etabonate ophthalmic gel ➤ Pilot study: Photobiomodulation improves BCVA in patients with dry AMD ➤ Positive interim data in trial for gene therapy for GA ➤ Four Phase 3 studies of faricimab show up to 4-month treatment intervals for DME and wet AMD
Patients often seek their ophthalmologist’s expert opinion for the IOL they would recommend if they were in the patient’s situation. As a resident at Northwestern University, Hercules Logothetis, MD, and his mentor Robert Feder, MD, actually asked ophthalmologists about the technology they would choose for themselves.1
When multifocal lenses were first introduced, they were heralded as a means of providing both near and distance vision improvements for patients undergoing cataract surgery. These IOLs feature two main foci, but patients continually demanded better intermediate vision. In today’s world, one could argue intermediate vision is even more crucial than near for performing daily tasks such as using a computer, tablet, or smartphone.